(Q41669268)

6 October 2017

title

Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma (English)

1 reference

6 October 2017

Kemp J

1

1 reference

6 October 2017

Wanderer AA

2

1 reference

6 October 2017

Ramsdell J

3

1 reference

6 October 2017

Southern DL

4

1 reference

6 October 2017

Weiss S

5

1 reference

6 October 2017

Aaronson D

6

1 reference

6 October 2017

Grossman J

7

1 reference

6 October 2017

publication date

1 May 1999

1 reference

Annals of Allergy, Asthma & Immunology

6 October 2017

published in

1 reference

6 October 2017

volume

82

1 reference

6 October 2017

issue

5

1 reference

6 October 2017

page(s)

463-471

1 reference

Damage of the airway epithelium and bronchial reactivity in patients with asthma

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Mucosal inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Use of inhaled corticosteroids in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Effect of Early vs Late Intervention With Inhaled Corticosteroids in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Budesonide. An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Fifteen-year interval spirometric evaluation of the Oregon predictive equations.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

A quantitative assay of cortisol in human plasma by high performance liquid chromatography using a selective chemically bonded stationary phase

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Average Partial Association in Three-Way Contingency Tables: A Review and Discussion of Alternative Tests

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Undertreatment in a nonselected population of adult patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Association between availability of non-prescription beta 2 agonist inhalers and undertreatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Inhaled corticosteroids: benefits and risks

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Inhaled glucocorticoids for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

A new approach to the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Single-dose inhaled budesonide in subjects with chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Budesonide treatment of moderate and severe asthma in children: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962722-6

7 January 2021

10.1016/S1081-1206(10)62722-6

Identifiers

DOI

1 reference

release_t2eywzcxfvffdhzyaxytvptghe

6 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t2eywzcxfvffdhzyaxytvptghe

24 November 2022

mapped directly with Wikidata item

1 reference